An evaluation in Kenya of the cluster-randomised RTS,S/AS01 Malaria Vaccine Implementation Pilot through routine health systems in moderate to high malaria transmission settings in sub-Saharan Africa

Request For Proposals

General Information

   May 19, 2017
   Jun 29, 2017

Contact information


Goods, Works and Services

Vaccines   Miscellaneous health services   Health and safety services   Health services   Administrative healthcare services  

Original Text


WHO has published a Request for Proposals (RFP) to undertake a robust evaluation the pilot implementation of the malaria vaccine RTS,S/AS01. The Ministries of Health of Ghana, Kenya and Malawi are planning to deploy the vaccine in selected moderate to high malaria transmission settings during 2018. The RFP seeks to identify Evaluation Partners who will develop country-specific evaluation protocols, in conjunction with WHO and based on a master protocol developed by WHO. The objectives will be to:

(i)            Evaluate the feasibility of deploying the 4-dose regimen of the RTS,S malaria vaccine through the routine immunisation programme. 

(ii)           Consolidate the safety profile of the vaccine when routinely deployed, and

(iii)          Estimate the impact of the routine delivery of RTS,S/AS01 on all-cause mortality in children aged 5-48 months.


The RFP for Kenya can be accessed here. 


Four hard copies of the technical proposal and budget should be submitted by 5 p.m. Geneva time on 29 June 2017.


Related documents:

RTSS RFP budget template. v16may17.xlsx 4. RTSS RFP v18may17.Kenya. 2017HTMGMP02.pdf

More information: Click here
Please note that this notice is for your information only.
We try our best to have the most accurate and up-to-date information available on our web site, but we cannot guarantee that all of the information provided is error-free.
If you have any updates, corrections, or complaints related to this notice, please contact the responsible purchaser directly.